| Financial Year |
March 31 2023 |
| Monetary Funds |
1,246,059,522.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,851,303.74 |
| Accounts Receivable |
1,521,580,280.69 |
| Advances to Suppliers |
45,807,366.82 |
| Other Receivables |
70,232,185.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
665,277,674.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,201,871.80 |
| Other Current Assets |
19,546,641.89 |
| Total Current Assets |
3,722,923,883.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,663,881.13 |
| Long-term Equity Investment |
47,695,585.40 |
| Investment Properties |
5,569,488.86 |
| Fixed Assetes |
143,944,215.55 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,602,334.57 |
| R&D expenses |
10,854,200.42 |
| Goodwill |
89,199,266.18 |
| Long-Term Deferred and Prepaid Expenses |
11,685,652.67 |
| Deferred Income Tax Assets |
171,698,146.04 |
| Other Non-Current Assets |
38,196,461.10 |
| Sub-Total of Non-Current Assets |
624,830,708.91 |
| Total Assets |
4,347,754,592.02 |
| Short-Term Loans |
583,829,142.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
78,050,888.33 |
| Accounts Payable |
945,383,267.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
73,048,434.65 |
| Taxes Payable |
28,775,023.77 |
| Interest Payable |
-- |
| Dividend Payable |
580,573.11 |
| Other payables |
17,197,408.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,359,527.03 |
| Other Current Liabilities |
14,980,418.76 |
| Sub-Total of Current Liabilities |
2,489,519,880.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
57,396,417.49 |
| Deferred Income Tax Liabilities |
3,099,571.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
105,395,920.44 |
| Total Liabilities |
2,594,915,800.77 |
| Paid-In Capital(Or Share Stock) |
232,637,638.00 |
| Capital Surplus |
778,178,603.48 |
| Surplus Reserve |
22,966,373.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
403,071,401.57 |
| Minority Stockholder's Interest |
315,719,999.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,437,118,791.37 |
| Owner's Equity（Stockholder's Equity） |
1,752,838,791.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,347,754,592.02 |
